Alcon Inc.

ALC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2010 FY2009 FY2008 FY2007
Operating Activities
Net Income $256.0M $2.21B $2.01B $2.05B $1.59B
Depreciation & Amortization — — — — —
Depreciation $215.0M $212.0M $194.0M $167.0M $159.0M
Amortization $1.03B $60.0M $24.0M $29.0M $51.0M
Stock-Based Compensation $71.0M — $74.0M $83.0M $84.0M
Net Cash from Operating Activities $1.22B $2.38B $2.42B $2.03B $1.47B
Investing Activities
Capital Expenditures $415.0M $309.0M $342.0M $302.0M $227.0M
Business Acquisitions — $529.0M $149.0M $23.0M $111.0M
Net Cash from Investing Activities $-679.0M $-1.71B $-390.0M $-365.0M $-227.0M
Financing Activities
Dividends Paid — $1.04B $1.05B $749.0M $613.0M
Stock Repurchases — $33.0M $7.0M $127.0M $1.00B
Net Cash from Financing Activities $-539.0M $-1.15B $-1.48B $-1.33B $-607.0M
Net Change in Cash $10.0M $-482.0M $558.0M $315.0M $645.0M
Free Cash Flow $803.0M $2.07B $2.07B $1.73B $1.24B
← Newer Page 2 of 2 Older →